IntelGenx Corp. (IGXT.OB) Hits Milestone with VersaFilm Oral Thin Film Technology
There’s been a lot of news lately about major pharmaceutical company’s pipelines getting very thin. Patents are expiring for some major drugs, most notably, Lipitor, Pfizer’s multi-billion dollar a year drug and one of the greatest selling drugs of all time. Big pharma has never been known for strength in developing new compounds, but rather in scouring the smaller biotechs for promising drug candidates and acquiring them in an attempt to secure prosperous years to come. In the next several years, as pipelines continue to wear thin, mergers and acquisitions within the biotechnology industry very well could be the talk…